Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis.

Liat Samuelov Ron BochnerLee MagalKiril MalovitskiNadav SagivJanna NousbeckAviad KerenDana Fuchs-TelemOfer Sarig Amos Gilhar Eli Sprecher

Published in: Experimental dermatology (2021)

Our results support the notion that vorinostat, a prototypic HDAC inhibitor, may be of potential use in the treatment of psoriasis and other hyperproliferative skin disorders.

Keyphrases

histone deacetylase
combination therapy
replacement therapy
soft tissue